Author:
Borup Gitte,Bach Karin Friis,Schmiegelow Merete,Wallach-Kildemoes Helle,Bjerrum Ole Jannik,Westergaard Niels
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference31 articles.
1. Pushparajah DS, Geissler J, Westergaard N. EUPATI: collaboration between patients, academia and industry to champion the informed patient in the research and development of medicines. Journal of Medicines Development Sciences. 2015;1(1):74–80.
2. Hoos A, Anderson J, Boutin M, et al. Partnering with patients in the development and lifecycle of medicines: a call for action. Therapeutic Innovation & Regulatory Science. 2015.
3. European Medicines Agency. The patient’s voice in the evaluation of medicines: how patients can contribute to assessment of benefit and risk. 2013. http://www.ema.europa.eu/. Accessed September 14, 2015.
4. Tufts Center for the Study of Drug Development. Cost to develop and win marketing approval for a new drug is $2.6 billion. Tufts Center for the Study of Drug Development Web site. http://csdd.tufts.edu/news/complete_story/pr_tufts_csdd_2014_cost_study. Published November 18, 2014. Accessed September 14, 2015.
5. Smits RE, Boon WP. The role of users in innovation in the pharmaceutical industry. Drug Discov Today. 2008;13(7):353–359.
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献